[The heparin and trental treatment of patients with the hemorrhagic form of erysipelas].
Activation of procoagulant hemostasis and signs of increased consumption of thrombocytes were indications for the treatment of patients with hemorrhagic erysipelas by means of heparine (60 patients) and trental (30 patients). Heparine was introduced subcutaneously as "minidoses" by means of electrophoresis into the inflammation focus. Heparine produced a positive effect on hemostasis and fibrinolysis, favoured rapid disappearance of the hemorrhagic syndrome, prevention of complications of erysipelas. Trental effected positively thrombocytic hemostasis, local manifestations of the hemorrhagic syndrome but did not prevent the development of thrombophlebitis as complication of the disease.
Cherkasov
V L
VL
Nakisbekova
G O
GO
Smolianitskiĭ
A Ia
AIa
Samotolkin
K N
KN
D000293:Adolescent; D000328:Adult; D000368:Aged; D001777:Blood Coagulation / Q000187:drug effects; D004341:Drug Evaluation; D004886:Erysipelas / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006470:Hemorrhage / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000627:therapeutic use*
D006493:Heparin; D010431:Pentoxifylline
Lechenie bol'nykh s gemorragicheskoĭ formoĭ rozhi geparinom i trentalom.